This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03456/identifier/pdb/
n4http://bio2rdf.org/drugbank:
n14http://linked.opendata.cz/resource/drugbank/drug/DB03456/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n6http://linked.opendata.cz/resource/drugbank/drug/DB03456/identifier/pubchem-substance/
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03456/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n9http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB03456/identifier/chemspider/

Statements

Subject Item
n2:DB03456
rdf:type
n8:Drug
n8:description
N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide is a solid. This compound belongs to the n-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid (or a derivative thereof) which bears an acyl group at its terminal nitrogen atom. It is known to target cathepsin K.
n8:group
experimental
owl:sameAs
n4:DB03456 n7:DB03456
dcterms:title
N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide
adms:identifier
n6:46504451 n10:DB03456 n11:NBL n13:4451045 n14:5288988
n8:IUPAC-Name
n9:271B49F0-363D-11E5-9242-09173F13E4C5
n8:InChI
n9:271B49F6-363D-11E5-9242-09173F13E4C5
n8:Molecular-Formula
n9:271B49F5-363D-11E5-9242-09173F13E4C5
n8:Molecular-Weight
n9:271B49F2-363D-11E5-9242-09173F13E4C5
n8:Monoisotopic-Weight
n9:271B49F3-363D-11E5-9242-09173F13E4C5
n8:SMILES
n9:271B49F4-363D-11E5-9242-09173F13E4C5
n8:Water-Solubility
n9:271B49EE-363D-11E5-9242-09173F13E4C5
n8:logP
n9:271B49EF-363D-11E5-9242-09173F13E4C5 n9:271B49EC-363D-11E5-9242-09173F13E4C5
n8:logS
n9:271B49ED-363D-11E5-9242-09173F13E4C5
n8:H-Bond-Acceptor-Count
n9:271B49FC-363D-11E5-9242-09173F13E4C5
n8:H-Bond-Donor-Count
n9:271B49FD-363D-11E5-9242-09173F13E4C5
n8:InChIKey
n9:271B49F7-363D-11E5-9242-09173F13E4C5
n8:Polar-Surface-Area--PSA-
n9:271B49F8-363D-11E5-9242-09173F13E4C5
n8:Polarizability
n9:271B49FA-363D-11E5-9242-09173F13E4C5
n8:Refractivity
n9:271B49F9-363D-11E5-9242-09173F13E4C5
n8:Rotatable-Bond-Count
n9:271B49FB-363D-11E5-9242-09173F13E4C5
n8:Bioavailability
n9:271B4A02-363D-11E5-9242-09173F13E4C5
n8:Ghose-Filter
n9:271B4A04-363D-11E5-9242-09173F13E4C5
n8:MDDR-Like-Rule
n9:271B4A05-363D-11E5-9242-09173F13E4C5
n8:Number-of-Rings
n9:271B4A01-363D-11E5-9242-09173F13E4C5
n8:Physiological-Charge
n9:271B4A00-363D-11E5-9242-09173F13E4C5
n8:Rule-of-Five
n9:271B4A03-363D-11E5-9242-09173F13E4C5
n8:Traditional-IUPAC-Name
n9:271B49F1-363D-11E5-9242-09173F13E4C5
n8:pKa--strongest-acidic-
n9:271B49FE-363D-11E5-9242-09173F13E4C5
n8:pKa--strongest-basic-
n9:271B49FF-363D-11E5-9242-09173F13E4C5